Spain: SpliceBio closes US$135m Series B financing round
SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, has closed a US$135m Series B...
Italy: Faes Farma acquires SIFI to expand ophthalmic franchise
Faes Farma, a Spain-based pharmaceutical company listed on the Spanish stock exchange, is acquiring SIFI, an Italy-based international ophthalmic company, from shareholders – the...
Denmark: Nordic Capital partners with Minerva Imaging to support growth journey in radiopharmaceutical space
Nordic Capital is making an undisclosed investment in Minerva, a Denmark-based CRO and CDMO specialising in the development of targeted radioligand therapies. The investment,...
UK: Spectris confirms proposal from Advent International
Spectris, a UK-listed supplier of precision instrumentation and controls, has received a possible cash offer for its shares from US-based PE firm, Advent International,...
The Netherlands: Merus raises US$300m from underwritten public offering
Nasdaq-listed Merus, an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates, has priced an underwritten public offering of 5,263,158 common shares...
India: Advent partners with Felix to build generic animal health leader
US-based PE firm, Advent, is investing US$$175m via primary and secondary for a significant minority stake in Dublin headquartered Felix Pharmaceuticals, a developer and...
UK: L’Oréal Groupe to acquire a majority stake in Medik8
Global beauty player, L'Oréal Groupe to acquire a majority stake in the British skincare brand Medik8. As part of the transaction, Inflexion, a European mid-market...
UK: HIG Capital completes acquisition of ITH Group
US-based alternative investment firm, HIG Capital, has completed the acquisition of ITH Group, a UK provider of aseptic pharmaceutical compounding services, in partnership with...
UK: Hakim Group to accelerate expansion plans with investment from ICG
Hakim Group, the UK’s largest family of independent opticians and audiologists, bring global alternative asset manager, ICG, on board as an additional investment partner...
UK: Omega Healthcare Investors revealed as acquirer of Four Seasons’ remaining care homes
Caring Times, a UK publication for care managers, owners and directors, has named US-based Omega Healthcare Investors as the acquirer of the majority of...
Advertisement
